Integra LifeSciences (NASDAQ:IART – Get Free Report) updated its third quarter 2026 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of 0.530-0.610 for the period, compared to the consensus earnings per share estimate of 0.560. Get Integra LifeSciences alerts:View Our Latest Stock Analysis on IARTIntegra LifeSciences Stock Down 11.4%Shares of NASDAQ IART traded down $2.25 during mid-day trading on Wednesday, reaching $17.51. Integra LifeSciences has set its Q3 2026 guidance at 0.530-0.610 EPS and its FY 2026 guidance at 2.400-2.500 EPS. Featured StoriesReceive News & Ratings for Integra LifeSciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integra LifeSciences and related companies with MarketBeat.com's FREE daily email newsletter.